Clinical Trial Update: A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma [Phase 1]

View source ↗

Summary

Phase 1 study of oral azacitidine in combination with romidepsin in advanced solid tumors, with expansion cohorts in virally mediated cancers and liposarcoma; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma

Drugs mentioned

• CC-486 (oral azacitidine) (azacitidine)
• Istodax (romidepsin) (romidepsin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Solid Tumors, Virally Mediated Cancers and Liposarcoma | Phase 1 | Status: COMPLETED